American Urological Association

TL;DR: The Prostate Cancer Clinical Guideline Update Panel is a free resource for clinicians and researchers to assess the need for and ability to evaluate the risks and benefits of utilizing the PSA in men and women diagnosed with prostate cancer.

TL;DR: This joint EAU/AUA Nephrolithiasis Guideline Panel performed a systematic review of the English language literature published since 1997 and a comprehensively analyzed outcomes data from the identified studies, dedicating this report to the memory of Dr. Joseph W. Segura whose vision, integrity, and perseverance led to the establishment of the first international guideline project.

TL;DR: Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.

TL;DR: To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic hyperplasia, new pharmacotherapies and technologies have emerged which have impacted treatment algorithms.